Rockwell Medical Inc. (RMTI) Business Metric Overview - Stocknear

Rockwell Medical Inc.

NASDAQ: RMTI · Real-Time Price · USD
1.62
-0.06 (-3.57%)
At close: Sep 05, 2025, 3:59 PM
1.64
1.23%
After-hours: Sep 05, 2025, 05:11 PM EDT

Rockwell Medical Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Dec 31, 2018
Concentrate Products Revenue 16.07M 18.59M 50.47M 28.3M 25.82M 22.66M 59.7M 21.57M 16.79M
Concentrate Products Revenue Growth -13.55% -63.17% +78.32% +9.62% +13.92% -62.04% +176.72% +28.52% n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019
Non-Us Revenue 1.88M 2.48M 5.42M 2.07M 2.62M 1.74M 5.11M 4.03M 65K 65K 133K 65K 338K 62K 62K 62K 58K 58K 59K 56K 56K 56K 1.33M
Non-Us Revenue Growth -24.05% -54.28% +161.96% -21.12% +50.57% -65.90% +26.77% +6100.00% 0.00% -51.13% +104.62% -80.77% +445.16% 0.00% 0.00% +6.90% 0.00% -1.69% +5.36% 0.00% 0.00% -95.78% n/a
United States Revenue 14.19M 16.44M 45.08M 26.25M 23.21M 20.93M 54.6M 19.74M n/a n/a n/a 193K 209K 159K 179K 217K 215K 225K 301K 228K 182K 199K 13.94M
United States Revenue Growth -13.67% -63.54% +71.74% +13.09% +10.87% -61.66% +176.59% n/a n/a n/a -100.00% -7.66% +31.45% -11.17% -17.51% +0.93% -4.44% -25.25% +32.02% +25.27% -8.54% -98.57% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 3.85M 4.4M 4.15M 4.3M 4.04M 4.37M 3.25M 3.44M 3.83M 3.75M 4.15M 4.02M 5.3M 4.27M 4.74M 5.42M 5.14M 5.77M 6.55M 5.29M 4.87M 7.35M 6.56M 6.45M 7.72M 9.32M 7.9M 6.16M 5.69M 3.33M 5.87M 4.79M 6.54M 6.1M 6.05M 5.07M 5.01M 4.99M 6.09M 3.83M 3.84M 5.33M
Selling, General, and Administrative Revenue Growth -12.49% +6.10% -3.58% +6.64% -7.67% +34.50% -5.69% -9.93% +2.05% -9.69% +3.34% -24.24% +24.06% -9.81% -12.62% +5.38% -10.89% -11.82% +23.76% +8.69% -33.73% +12.01% +1.67% -16.39% -17.24% +18.01% +28.27% +8.23% +70.80% -43.24% +22.50% -26.75% +7.22% +0.84% +19.32% +1.11% +0.55% -18.11% +59.08% -0.20% -27.98% n/a
Research and Development Revenue n/a n/a 1K n/a n/a 18K 168K 494K 167K 278K 156K 469K 926K 1.57M 1.39M 1.22M 2.42M 1.81M 1.91M 1.75M 1.62M 1.82M 1.96M 1.47M 2.96M 497.28K 2.71M 808.19K 1.56M 1.67M 2.13M 1.3M 1.68M 1.21M 1.2M 1.26M 2.06M 1.31M 2.03M 1.25M 885.26K 799.59K
Research and Development Revenue Growth n/a -100.00% n/a n/a -100.00% -89.29% -65.99% +195.81% -39.93% +78.21% -66.74% -49.35% -40.91% +12.73% +13.84% -49.46% +33.55% -5.24% +9.40% +7.98% -11.31% -6.85% +32.63% -50.15% +494.90% -81.64% +235.17% -48.16% -6.45% -21.63% +62.99% -22.13% +37.92% +1.18% -4.84% -38.84% +56.97% -35.24% +62.81% +40.83% +10.71% n/a
Sales and Marketing Revenue 572K 711K 843K 726K 586K 594K 541K 556K 530K 498K 352K 762K 526K 455K 873K 1.54M 1.47M 1.85M 2.13M 1.67M 2M 2.07M 1.9M 1.83M 2.22M 3.1M 288.17K 121.87K 164.37K 215.08K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth -19.55% -15.66% +16.12% +23.89% -1.35% +9.80% -2.70% +4.91% +6.43% +41.48% -53.81% +44.87% +15.60% -47.88% -43.35% +4.97% -20.69% -13.22% +27.80% -16.42% -3.67% +9.04% +4.03% -17.64% -28.47% +976.58% +136.45% -25.86% -23.58% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a